• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注射用 PLGA 多孔微球复合 hAFSCs 用于细胞型心肌成形术。

Injectable PLGA porous beads cellularized by hAFSCs for cellular cardiomyoplasty.

机构信息

Department of Chemical Engineering, National Tsing Hua University, Hsinchu 30013, Taiwan.

出版信息

Biomaterials. 2012 Jun;33(16):4069-77. doi: 10.1016/j.biomaterials.2012.02.024. Epub 2012 Mar 3.

DOI:10.1016/j.biomaterials.2012.02.024
PMID:22386922
Abstract

Cellular cardiomyoplasty has been limited by poor graft retention after cell transplantation. To ensure good retention of the engrafted cells, a microfluidic device was used to fabricate spherical porous beads of poly(D,L-lactic-co-glycolic acid) as a platform for cell delivery. The beads thus obtained had a relatively uniform size, a highly porous structure, and a favorably interconnected interior architecture, to facilitate the transportation of oxygen and nutrients. These porous beads were loaded with human amniotic fluid stem cells (hAFSCs) to generate cellularized microscaffolds. Live/dead assay demonstrated that most of the cells in the porous constructs were viable. The hAFSCs that were grown in beads formed a complex three-dimensional organization with well-preserved extracellular matrices (ECM) according to their porous structure. Retention of the administered beads was clearly identified at the site of engraftment following an experimentally induced myocardial infarction in a rat model. The results of echocardiography, magnetic resonance imaging, and histological analyses suggest that the transplantation of hAFSC beads into an infarcted heart could effectively maintain its gross morphology, prevent successive ventricular expansion, and thereby improve the post-infarcted cardiac function. Immunofluorescent staining revealed that the microenvironment that was provided by the infarcted myocardium might offer cues for the induction of the engrafted hAFSCs into angiogenic and cardiomyogenic lineages. Our results demonstrate that the cellularized beads with endogenously secreted ECM were of sufficient physical size to be entrapped in the interstitial tissues following transplantation, thereby benefiting the infarcted heart.

摘要

细胞心肌成形术由于细胞移植后移植物保留效果不佳而受到限制。为确保移植细胞的良好保留,使用微流控设备制造聚(D,L-乳酸-共-乙醇酸)的球形多孔珠作为细胞输送的平台。由此获得的珠粒具有相对均匀的尺寸、高度多孔的结构和有利的相互连接的内部结构,有利于氧气和营养物质的运输。这些多孔珠被加载有人羊水干细胞(hAFSCs)以生成细胞化微支架。活/死检测表明,多孔结构中的大多数细胞都是存活的。在大鼠模型中诱导实验性心肌梗死后,在植入部位明显可以识别到已给药珠粒的保留。超声心动图、磁共振成像和组织学分析的结果表明,将 hAFSC 珠粒移植到梗死心脏中可以有效维持其大体形态,防止心室连续扩张,从而改善梗死后的心脏功能。免疫荧光染色显示,梗死心肌提供的微环境可能为植入的 hAFSCs 诱导为血管生成和心肌生成谱系提供线索。我们的结果表明,具有内部分泌型细胞外基质的细胞化珠粒具有足够的物理尺寸,可以在移植后被困在间质组织中,从而有益于梗死心脏。

相似文献

1
Injectable PLGA porous beads cellularized by hAFSCs for cellular cardiomyoplasty.注射用 PLGA 多孔微球复合 hAFSCs 用于细胞型心肌成形术。
Biomaterials. 2012 Jun;33(16):4069-77. doi: 10.1016/j.biomaterials.2012.02.024. Epub 2012 Mar 3.
2
Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem-cell bodies enriched with endogenous ECM.利用富含内源性细胞外基质的人羊膜液干细胞体增强心肌梗死后的细胞保留和功能益处。
Biomaterials. 2011 Aug;32(24):5558-67. doi: 10.1016/j.biomaterials.2011.04.031. Epub 2011 May 8.
3
Cardiac repair with injectable cell sheet fragments of human amniotic fluid stem cells in an immune-suppressed rat model.注射用人类羊水干细胞片修复免疫抑制大鼠心脏。
Biomaterials. 2010 Sep;31(25):6444-53. doi: 10.1016/j.biomaterials.2010.04.069.
4
Cellular cardiomyoplasty with human amniotic fluid stem cells: in vitro and in vivo studies.细胞型心肌成形术联合人羊膜间充质干细胞:体内外研究。
Tissue Eng Part A. 2010 Jun;16(6):1925-36. doi: 10.1089/ten.TEA.2009.0728.
5
Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy.细胞心肌成形术和心脏组织工程学用于心肌治疗。
Adv Drug Deliv Rev. 2010 Jun 15;62(7-8):784-97. doi: 10.1016/j.addr.2010.03.001. Epub 2010 Mar 6.
6
Spherically symmetric mesenchymal stromal cell bodies inherent with endogenous extracellular matrices for cellular cardiomyoplasty.用于细胞性心肌成形术的、具有内源性细胞外基质的球形对称间充质基质细胞体。
Stem Cells. 2009 Mar;27(3):724-32. doi: 10.1634/stemcells.2008-0944.
7
Trans-coronary transplantation may be an optimal route in cellular cardiomyoplasty with stem cells.经冠状动脉移植可能是干细胞心肌成形术中的最佳途径。
Med Hypotheses. 2007;69(6):1212-8. doi: 10.1016/j.mehy.2007.04.013. Epub 2007 Jun 6.
8
Injectable cell constructs fabricated via culture on a thermoresponsive methylcellulose hydrogel system for the treatment of ischemic diseases.通过在热响应甲基纤维素水凝胶系统上培养制备的可注射细胞构建体,用于治疗缺血性疾病。
Adv Healthc Mater. 2014 Aug;3(8):1133-48. doi: 10.1002/adhm.201300605. Epub 2014 Jan 27.
9
Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts.通心络联合自体骨髓间充质干细胞促进细胞心肌成形术对心肌梗死后猪心脏的影响。
Chin Med J (Engl). 2007 Aug 20;120(16):1416-25.
10
Poly(D,L lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells.聚(D,L-乳酸-乙醇酸)微球作为多能干细胞的可生物降解微载体
Biomaterials. 2004 Nov;25(26):5763-71. doi: 10.1016/j.biomaterials.2004.01.027.

引用本文的文献

1
Alternative Techniques for Porous Microparticle Production: Electrospraying, Microfluidics, and Supercritical CO.多孔微粒生产的替代技术:电喷雾法、微流控技术和超临界二氧化碳法
Pharm Res. 2025 Sep 11. doi: 10.1007/s11095-025-03923-2.
2
Review on Electrospray Nanoparticles for Drug Delivery: Exploring Applications.用于药物递送的电喷雾纳米颗粒综述:探索应用
Polym Adv Technol. 2024 Jul;35(7). doi: 10.1002/pat.6507. Epub 2024 Jul 16.
3
Cell-microsphere based living microhybrids for osteogenesis regulating to boosting biomineralization.
基于细胞-微球的活性微杂交体用于调节骨生成以促进生物矿化。
Regen Biomater. 2024 Oct 29;11:rbae125. doi: 10.1093/rb/rbae125. eCollection 2024.
4
Microparticle Mediated Delivery of Apelin Improves Heart Function in Post Myocardial Infarction Mice.微颗粒介导的 Apelin 递呈改善心肌梗死后小鼠的心脏功能。
Circ Res. 2024 Sep 13;135(7):777-798. doi: 10.1161/CIRCRESAHA.124.324608. Epub 2024 Aug 15.
5
Elastic porous microspheres/extracellular matrix hydrogel injectable composites releasing dual bio-factors enable tissue regeneration.弹性多孔微球/细胞外基质水凝胶可注射复合材料释放双重生物因子促进组织再生。
Nat Commun. 2024 Feb 14;15(1):1377. doi: 10.1038/s41467-024-45764-4.
6
Precise Fabrication of Porous Microspheres by Iso-Density Emulsion Combined with Microfluidics.等密度乳液结合微流控技术精确制备多孔微球
Polymers (Basel). 2022 Jun 30;14(13):2687. doi: 10.3390/polym14132687.
7
Microcarriers in application for cartilage tissue engineering: Recent progress and challenges.微载体在软骨组织工程中的应用:最新进展与挑战
Bioact Mater. 2022 Jan 25;17:81-108. doi: 10.1016/j.bioactmat.2022.01.033. eCollection 2022 Nov.
8
Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction.心脏组织工程学在心肌梗死管理中的最新进展。
Cells. 2021 Sep 25;10(10):2538. doi: 10.3390/cells10102538.
9
Bioactive Scaffolds in Stem Cell-Based Therapies for Myocardial Infarction: a Systematic Review and Meta-Analysis of Preclinical Trials.基于干细胞的心肌梗死治疗中的生物活性支架:临床前试验的系统评价和荟萃分析。
Stem Cell Rev Rep. 2022 Aug;18(6):2104-2136. doi: 10.1007/s12015-021-10186-y. Epub 2021 Aug 31.
10
Modeling Endothelialized Hepatic Tumor Microtissues for Drug Screening.构建用于药物筛选的内皮化肝肿瘤微组织模型。
Adv Sci (Weinh). 2020 Sep 21;7(21):2002002. doi: 10.1002/advs.202002002. eCollection 2020 Nov.